Drug Side Effects
Search
PLEUROPERITONEAL COMMUNICATION
PLEUROPERITONEAL COMMUNICATION
was reported 143 times
PLEUROPERITONEAL COMMUNICATION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
1
0.0002
1
Vitamin D3 Analog [EPC]
2
0.0001
2
Erythropoiesis-stimulating Agent [EPC]
4
0.0001
3
Nonergot Dopamine Agonist [EPC]
1
0.0001
4
Antimetabolite Immunosuppressant [EPC]
1
0.0000
5
alpha-Adrenergic Blocker [EPC]
4
0.0000
6
Xanthine Oxidase Inhibitor [EPC]
4
0.0000
7
Copper-containing Intrauterine Device [EPC]
1
0.0000
8
Central alpha-2 Adrenergic Agonist [EPC]
1
0.0000
9
Complement Inhibitor [EPC]
1
0.0000
10
Loop Diuretic [EPC]
8
0.0000
11
Dihydropyridine Calcium Channel Blocker [EPC]
5
0.0000
12
beta-Adrenergic Blocker [EPC]
4
0.0000
13
Aldosterone Antagonist [EPC]
2
0.0000
14
Histamine-1 Receptor Antagonist [EPC]
1
0.0000
15
Proteasome Inhibitor [EPC]
1
0.0000
16
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
17
Vitamin C [EPC]
3
0.0000
18
Osmotic Laxative [EPC]
2
0.0000
19
Insulin Analog [EPC]
3
0.0000
20
Vitamin D [EPC]
2
0.0000
21
Vitamin B12 [EPC]
2
0.0000
22
Corticosteroid [EPC]
6
0.0000
23
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
24
Kinase Inhibitor [EPC]
1
0.0000
25
Platelet Aggregation Inhibitor [EPC]
1
0.0000
26
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000